1. Home
  2. SEED vs INKT Comparison

SEED vs INKT Comparison

Compare SEED & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEED
  • INKT
  • Stock Information
  • Founded
  • SEED 1997
  • INKT 2017
  • Country
  • SEED China
  • INKT United States
  • Employees
  • SEED N/A
  • INKT N/A
  • Industry
  • SEED Farming/Seeds/Milling
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • SEED Consumer Staples
  • INKT Health Care
  • Exchange
  • SEED Nasdaq
  • INKT Nasdaq
  • Market Cap
  • SEED 37.6M
  • INKT 41.3M
  • IPO Year
  • SEED N/A
  • INKT 2021
  • Fundamental
  • Price
  • SEED $3.63
  • INKT $0.91
  • Analyst Decision
  • SEED
  • INKT Strong Buy
  • Analyst Count
  • SEED 0
  • INKT 1
  • Target Price
  • SEED N/A
  • INKT $9.00
  • AVG Volume (30 Days)
  • SEED 28.6K
  • INKT 94.3K
  • Earning Date
  • SEED 08-12-2024
  • INKT 08-08-2024
  • Dividend Yield
  • SEED N/A
  • INKT N/A
  • EPS Growth
  • SEED N/A
  • INKT N/A
  • EPS
  • SEED 1.16
  • INKT N/A
  • Revenue
  • SEED $12,834,525.00
  • INKT N/A
  • Revenue This Year
  • SEED N/A
  • INKT N/A
  • Revenue Next Year
  • SEED N/A
  • INKT N/A
  • P/E Ratio
  • SEED $2.95
  • INKT N/A
  • Revenue Growth
  • SEED 77.46
  • INKT N/A
  • 52 Week Low
  • SEED $1.37
  • INKT $0.75
  • 52 Week High
  • SEED $6.38
  • INKT $1.96
  • Technical
  • Relative Strength Index (RSI)
  • SEED 32.79
  • INKT 45.87
  • Support Level
  • SEED $3.48
  • INKT $0.85
  • Resistance Level
  • SEED $3.82
  • INKT $1.24
  • Average True Range (ATR)
  • SEED 0.32
  • INKT 0.11
  • MACD
  • SEED -0.09
  • INKT -0.00
  • Stochastic Oscillator
  • SEED 12.65
  • INKT 19.32

About SEED Origin Agritech Limited

Origin Agritech Ltd is a Chinese agricultural technology company. In crop seed biotechnologies, the company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: